We are live on ! Find out more
RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

1 hedge funds and large institutions have $32K invested in Ra Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 144 → 1 (-143)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $2.47B → $32K (-$2.47B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
1
Holders Change
-143
Holders Change %
-99.31%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
142
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$295M
2
RCM
RA Capital Management
Massachusetts
-$233M
3
BlackRock
BlackRock
New York
-$213M
4
BBA
Baker Bros. Advisors
New York
-$101M
5
AAM
Alpine Associates Management
Florida
-$96.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
51
Millennium Management
New York
– -$4.8M -100,043 Closed
Voloridge Investment Management
52
Voloridge Investment Management
Florida
– -$4.78M -99,642 Closed
CS
53
Candriam SCA
Luxembourg
– -$4.57M -99,523 Closed
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$4.75M -99,000 Closed
GI
55
GAMCO Investors
Connecticut
– -$4.66M -97,140 Closed
SG Americas Securities
56
SG Americas Securities
New York
– -$4.62M -96,238 Closed
PP
57
Paloma Partners
Connecticut
– -$4.44M -92,509 Closed
Bank of America
58
Bank of America
North Carolina
– -$4.38M -91,256 Closed
CL
59
CSS LLC
Illinois
– -$4.27M -88,973 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
60
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$4.08M -85,050 Closed
California Public Employees Retirement System
61
California Public Employees Retirement System
California
– -$3.77M -78,619 Closed
Two Sigma Advisers
62
Two Sigma Advisers
New York
– -$3.61M -75,181 Closed
Wells Fargo
63
Wells Fargo
California
– -$3.57M -74,447 Closed
GCL
64
Glazer Capital LLC
New York
– -$3.25M -67,754 Closed
BCM
65
Beryl Capital Management
California
– -$3.05M -63,484 Closed
HS
66
HighVista Strategies
Massachusetts
– -$3.04M -63,222 Closed
GH
67
GAM Holding
Switzerland
– -$2.99M -62,200 Closed
Swiss National Bank
68
Swiss National Bank
Switzerland
– -$2.85M -59,400 Closed
OTPPB
69
Ontario Teachers' Pension Plan Board
Ontario, Canada
– -$2.59M -54,030 Closed
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
– -$2.54M -52,894 Closed
Skandinaviska Enskilda Banken (SEB)
71
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$2.5M -52,000 Closed
BCM
72
Bluefin Capital Management
New York
– -$2.48M -51,559 Closed
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
– -$2.42M -50,313 Closed
SEC
74
Seven Eight Capital
New York
– -$2.42M -50,300 Closed
UBS Group
75
UBS Group
Switzerland
– -$2.3M -47,824 Closed
1 2
3
4 5

RARX Hedge Fund Activity: Q2 2020 in Review

1 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Ra Pharmaceuticals, Inc. Common Stock (RARX) for Q2 2020, worth a combined $32K — down 100% from $2.47B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of RARX and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was NEA Management Company, exiting entirely with an estimated $295M sold.

  • 1 institutional investor held Ra Pharmaceuticals, Inc. Common Stock (RARX) as of Q2 2020, down from 144 in Q1 2020.
  • Funds reported $32K of Ra Pharmaceuticals, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Ra Pharmaceuticals, Inc. Common Stock positions in Q2 2020 and 142 closed out, a net change of -142 holders.
  • The largest Ra Pharmaceuticals, Inc. Common Stock seller in Q2 2020 was NEA Management Company, an estimated $295M sold.

Based on aggregated 13F filings for Q2 2020.